Author

Ielizaveta Gorodetska

Helmholtz-Zentrum Dresden-RossendorfORCID 0000-0002-3512-0462Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:drug response / drug discovery· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1

Frequent Co-Authors

Anna DubrovskaiD· 3 shared Annett LingeiD· 2 shared Ayşe Sedef KöseeriD· 2 shared Mechthild KrauseiD· 2 shared Uğur KahyaiD· 2 shared Vasyl Lukiyanchuk· 2 shared Aldo Leal‐EgañaiD· 1 shared Alexandra Kegler· 1 shared

Activity by Year

2025-2025 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Anna DubrovskaORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BioengineeringAdvanced SciencePeer-reviewedJul 24, 2025

3D Microphysiological Tumor Model for Dual-Targeting CAR T Cell Immunotherapy

Xuan Peng, Željko Janićijević, Liliana Rodrigues Loureiro…·Larysa Baraban

This paper develops a 3D tumor model to test dual-targeting CAR T cell therapy and shows its effectiveness against solid tumors.

7 citations

humanorganoid / primary culture

𝕏 PostBluesky

Cancer BiologybioRxivPreprintApr 22, 2025

Glutamine transporters regulate prostate cancer radiosensitivity through NUPR1-mediated stress response

Uğur Kahya, Vasyl Lukiyanchuk, Ielizaveta Gorodetska…·Anna Dubrovska

This study shows that glutamine transporters regulate prostate cancer radiosensitivity via NUPR1-mediated stress response, with targeting these transporters enhancing radiosensitivity and improving treatment outcomes.

DOI 10.1101/2025.04.22.650063

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyJournal of Experimental & Clinical Cancer ResearchPeer-reviewedMar 23, 2025

Blood-based detection of MMP11 as a marker of prostate cancer progression regulated by the ALDH1A1-TGF-β1 signaling mechanism

Ielizaveta Gorodetska, Vasyl Lukiyanchuk, Marta Gawin…·Anna Dubrovska

This study identifies MMP11 as a blood-based biomarker for prostate cancer progression, regulated by the ALDH1A1-TGF-β1 signaling pathway.

11 citations

humanbulk RNA-seq

𝕏 PostBluesky

Ielizaveta Gorodetska · henhao